Wellington Biomedical Innovation Master Investors (Cayman) II L.P. sold MTSR
January 30, 2025 · Form 4 insider transaction
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. sold 4,365,079 shares of MTSR at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,365,079
Price
$0.00
Total value
N/A
Role10% owner
CompanyMTSR
SecuritySeries B Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateJanuary 30, 2025
Filing dateFebruary 3, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock automatically converted into Common Stock on a 2.349723-for-1 basis upon closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.